Form 4: Pulmonx Director Richard Ferrari Sells 8,000 Shares of Common Stock
Insider Transaction Report
Richard Ferrari, a Director at Pulmonx Corp, reported the sale of 8,000 shares of the company's common stock on June 12, 2025, reducing his beneficial ownership to 87,024 shares.
Summary
- Richard Ferrari, a Director of Pulmonx Corp (LUNG), reported a transaction involving the company's common stock.
- On June 12, 2025, Mr. Ferrari disposed of 8,000 shares of common stock.
- The shares were sold at a weighted average price of $3.16 per share, with individual transaction prices ranging from $3.13 to $3.20.
- Following this transaction, Mr. Ferrari's direct beneficial ownership stands at 87,024 shares of Pulmonx Corp common stock.
Sentiment
Score: 4
Explanation: The sale of shares by a director, while a common occurrence for personal financial planning, can sometimes be viewed as a slightly negative signal by investors, suggesting a potential lack of confidence or a move to diversify holdings.
Negatives
- The sale of 8,000 shares by a director may be interpreted by the market as a potential lack of confidence or a move to diversify holdings, which can be perceived negatively.
Stakeholder Impact
- Shareholders may interpret the director's sale as a negative signal, potentially impacting investor confidence and the company's stock price.
Key Dates
| Date | Description |
|---|---|
| 06/12/2025 | Date of transaction (sale of common stock) |
| 06/13/2025 | Date the Form 4 was signed by the reporting person's attorney-in-fact |
Recommendation
holdKeywords
Pulmonx Corp, LUNG, Richard Ferrari, Insider Trading, Form 4, Stock Sale, Director Transaction, Equity Sales
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.